News
GSK files Blenrep in EU, seeking return to market

GSK files Blenrep in EU, seeking return to market

Less than two years after pulling multiple myeloma therapy Blenrep off most markets around the world, GSK has filed for approval of the drug in the EU once again, hoping to restore its bloc

Featured Content

R&D
Frantz Maignan and Grant Brock podcast
Sponsored

Tips for on-time tech transfers that stay on budget

When it comes to life sciences manufacturing, there's nothing quite so daunting as a tech transfer - moving a product from development to commercialisation, or to a new facility or CDMO, pr

Oncology
ASCO 2024 - Steve Devine interview with Jonah Comstock

ASCO 2024 - Steve Devine

While advances in cell and gene therapies chip away at the need for bone marrow transplants, the transplantation field remains very much alive and in the midst of innovations of its own.

Sales & Marketing
Launch Excellence: Moments of Truth
Sponsored

Launch Excellence: Moments of Truth

The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.

Newsletters and Deep Dive
digital magazine

Latest News

News
GSK files Blenrep in EU, seeking return to market

GSK files Blenrep in EU, seeking return to market

Less than two years after pulling multiple myeloma therapy Blenrep off most markets around the world, GSK has filed for approval of the drug in the EU once again, hoping to restore its bloc

News
Cardurion heads crop of sizeable bio financings

Cardurion heads crop of sizeable bio financings

While the pace of biotech private rounds seems to have slowed a little of late, this week saw four big financings for Cardurion Pharma, Scorpion Therapeutics, CatalYm, and NGM Bio.

Views & Analysis

R&D
Frantz Maignan and Grant Brock podcast
Sponsored

Tips for on-time tech transfers that stay on budget

When it comes to life sciences manufacturing, there's nothing quite so daunting as a tech transfer - moving a product from development to commercialisation, or to a new facility or CDMO, pr

Deep Dive

Oncology
an orange number five

Oncology trials: Top 5 trends to watch

Innovative designs, accelerated early-stage research, novel drug classes, advanced imaging, and personalised treatment optimisation are reshaping the oncology trial landscape, as Advanced Clinical's Dr Ravi Karra explains.

White Papers & Webinar

Sales & Marketing
Launch Excellence: Moments of Truth
Sponsored

Launch Excellence: Moments of Truth

The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.

Podcasts & Video

R&D
Frantz Maignan and Grant Brock podcast
Sponsored

Tips for on-time tech transfers that stay on budget

When it comes to life sciences manufacturing, there's nothing quite so daunting as a tech transfer - moving a product from development to commercialisation, or to a new facility or CDMO, pr

Oncology
ASCO 2024 - Steve Devine interview with Jonah Comstock

ASCO 2024 - Steve Devine

While advances in cell and gene therapies chip away at the need for bone marrow transplants, the transplantation field remains very much alive and in the midst of innovations of its own.

Partner Content

R&D
6th Inflammasome Therapeutics Summit banner
Partner Content

6th Inflammasome Therapeutics Summit

In the rapidly evolving field of inflammasome therapeutics, the need for innovative approaches to overcome the preclinical and clinical hurdles is more critical than ever.

R&D
2nd Covalent Drug Discovery & Development Summit banner image
Partner Content

2nd Covalent Drug Discovery & Development Summit

Discover & Develop Selective, Clinically Validated & Novel Covalent Therapeutics to Expand the Targetable Proteome & Non-Cystine Amino Acid Space in Oncology, Immunology & B

R&D
7th TPD & Induced Proximity Summit banner image
Partner Content

7th TPD & Induced Proximity Summit

Fast-Track Discovery, Development & Approval of Selective, Safe & Clinically Relevant TACs & Glues for Degradation, Stabilization, & Phosphorylation to Successfully Address